Form 4: Director Byom Acquires Prestige Consumer Healthcare Stock

Director John E. Byom acquired 2,094 shares of Prestige Consumer Healthcare stock on August 5, 2025, as part of the director compensation program.

Summary

• John E. Byom, a director of Prestige Consumer Healthcare Inc., acquired 2,094 shares of common stock on August 5, 2025.
• The acquisition was part of the Issuer's director compensation program.
• The shares were received as restricted stock units, with a total value of $155,000, calculated using a closing stock price of $74.04 on August 5, 2025.
• Following the transaction, Byom directly owns 54,594 shares of Prestige Consumer Healthcare Inc.
• The restricted stock units vest on the first anniversary of the grant and will be settled by delivery of one share of common stock for each vested unit upon death, separation, or change in control.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a standard director compensation practice.

Positives

• Director Byom's acquisition reflects continued alignment with company success.
• The director compensation program uses restricted stock units, incentivizing long-term commitment.

Future Outlook

The restricted stock units vest on the first anniversary of the grant and will be settled by delivery of one share of common stock for each vested unit upon death, separation, or change in control.

Industry Context

Director stock acquisitions are common in publicly traded companies as part of compensation packages to align the interests of directors with those of shareholders.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash, stock options, and restricted stock units.
• The vesting schedule of one year is fairly standard for restricted stock units granted to directors.
• Comparing the total compensation value ($155,000) to director compensation at similar consumer healthcare companies (e.g., Church & Dwight, Helen of Troy) would provide further context.

Stakeholder Impact

• Shareholders: The acquisition aligns director interests with shareholder value.
• Employees: No direct impact on employees.
• Customers: No direct impact on customers.
• Suppliers: No direct impact on suppliers.
• Creditors: No direct impact on creditors.

Next Steps

• The reporting person will receive shares of common stock upon vesting of the restricted stock units on the first anniversary of the grant.
• The reporting person will report any future transactions in Prestige Consumer Healthcare Inc. securities.

Key Dates

Recommendation

The acquisition of shares by a director is a positive sign, but not significant enough to warrant a change in recommendation. A hold recommendation is appropriate.

Keywords

Prestige Consumer Healthcare, Director Compensation, Stock Acquisition, Restricted Stock Units, Form 4, Insider Trading